Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
2.83M
-
Shares change
-
+2.8M
-
Total reported value, excl. options
-
$23.6M
-
Value change
-
+$23.3M
-
Put/Call ratio
-
0.11
-
Number of buys
-
69
-
Price
-
$8.34
Significant Holders of bluebird bio, Inc. - COM NEW (BLUE) as of Q4 2024
80 filings reported holding BLUE - bluebird bio, Inc. - COM NEW as of Q4 2024.
bluebird bio, Inc. - COM NEW (BLUE) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.83M shares
.
Largest 10 shareholders include BlackRock, Inc. (709K shares), VANGUARD GROUP INC (525K shares), GEODE CAPITAL MANAGEMENT, LLC (234K shares), STATE STREET CORP (198K shares), UBS Group AG (106K shares), NATIONAL BANK OF CANADA /FI/ (81.7K shares), NORTHERN TRUST CORP (81.7K shares), Avidity Partners Management LP (81.6K shares), Lion Point Capital, LP (78.9K shares), and PFM Health Sciences, LP (75.8K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.